Skip to main content
Top
Gepubliceerd in:

12-05-2024

Undergoing Lung Surgery (PSA-Lung) was appropriate for symptom assessment after discharge

Auteurs: Xueyao Su, Yanyan Huang, Ruoyan Gong, Wei Xu, Wei Dai, Yang Pu, Jingwen Yu, Qingsong Yu, Lijun Zhang, Jiayuan Zhang, Qiuling Shi

Gepubliceerd in: Quality of Life Research | Uitgave 7/2024

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

To examine whether a 7-day or 24-h recall period of Perioperative Symptom Assessment for Patients Undergoing Lung Surgery (PSA-Lung) was appropriate for symptom assessment after discharge.

Methods

A total of 377 patients were recruited in a cohort study of patients who underwent lung surgery. We measured patient symptoms daily and weekly using the two recall period versions of the PSA-Lung scale, respectively. The psychometric properties of both versions were calculated. Spearman rank correlation coefficients and kappa (k) coefficients were used to measure the association between items score measured by the two version scales each week. Cohen’s d effect size and mixed linear model were used to measure responsiveness to change over time.

Results

Spearman rank correlation coefficients between the symptom scores generated by the 7-day and 24-h versions (range 0.48–0.77; all P < 0.05). The correlations increased in patients in stable condition (weekly symptom change < 2). Cronbach’s α coefficients for both ratings were > 0.87 and both had good test–retest reliability. The longitudinal analysis and Cohen’s d effect sizes showed that both ratings had good ability to detect changes in all items.

Conclusion

The 7-day retrospective scale was as effective as the 24-h retrospective scale in terms of psychometric performance. In the stage where the patient’s symptoms change rapidly, it is recommended to use the 24-h retrospective scale for symptom monitoring. On the contrary, in a stable state, it can be considered to use the 7-day retrospective scale for monitoring to reduce the patient’s burden.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020). Reduced lung-cancer mortality with volume CT screening in a randomized trial. New England Journal of Medicine, 382(6), 503–513.CrossRefPubMed de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020). Reduced lung-cancer mortality with volume CT screening in a randomized trial. New England Journal of Medicine, 382(6), 503–513.CrossRefPubMed
2.
go back to reference Fagundes, C. P., Shi, Q., Vaporciyan, A. A., Rice, D. C., Popat, K. U., Cleeland, C. S., & Wang, X. S. (2015). Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory. Journal of Thoracic and Cardiovascular Surgery, 150(3), 613-619.e612.CrossRefPubMed Fagundes, C. P., Shi, Q., Vaporciyan, A. A., Rice, D. C., Popat, K. U., Cleeland, C. S., & Wang, X. S. (2015). Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory. Journal of Thoracic and Cardiovascular Surgery, 150(3), 613-619.e612.CrossRefPubMed
3.
go back to reference Ljungqvist, O., Scott, M., & Fearon, K. C. (2017). Enhanced recovery after surgery: A review. JAMA Surgery, 152(3), 292–298.CrossRefPubMed Ljungqvist, O., Scott, M., & Fearon, K. C. (2017). Enhanced recovery after surgery: A review. JAMA Surgery, 152(3), 292–298.CrossRefPubMed
4.
go back to reference Huang, L., Frandsen, M. N., Kehlet, H., & Petersen, R. H. (2022). Early and late readmissions after enhanced recovery thoracoscopic lobectomy. European Journal of Cardiothoracic Surgery, 62, 3.CrossRef Huang, L., Frandsen, M. N., Kehlet, H., & Petersen, R. H. (2022). Early and late readmissions after enhanced recovery thoracoscopic lobectomy. European Journal of Cardiothoracic Surgery, 62, 3.CrossRef
5.
go back to reference Bao, F., Dimitrovska, N. T., Hu, S., Chu, X., & Li, W. (2020). Safety of early discharge with a chest tube after pulmonary segmentectomy. European Journal of Cardio-Thoracic Surgery, 58(3), 613–618.CrossRefPubMed Bao, F., Dimitrovska, N. T., Hu, S., Chu, X., & Li, W. (2020). Safety of early discharge with a chest tube after pulmonary segmentectomy. European Journal of Cardio-Thoracic Surgery, 58(3), 613–618.CrossRefPubMed
6.
go back to reference Vandrevala, T., Senior, V., Spring, L., Kelliher, L., & Jones, C. (2016). “Am I really ready to go home?”: A qualitative study of patients’ experience of early discharge following an enhanced recovery programme for liver resection surgery. Supportive Care in Cancer, 24(8), 3447–3454.CrossRefPubMed Vandrevala, T., Senior, V., Spring, L., Kelliher, L., & Jones, C. (2016). “Am I really ready to go home?”: A qualitative study of patients’ experience of early discharge following an enhanced recovery programme for liver resection surgery. Supportive Care in Cancer, 24(8), 3447–3454.CrossRefPubMed
7.
go back to reference Zhang, J., Su, X., Xu, W., Yu, Q., Dai, W., Wang, Y., Zhuang, X., Li, Q., Wang, X. S., & Shi, Q. (2022). Identifying patients who suffered from post-discharge cough after lung cancer surgery. Supportive Care in Cancer, 30(9), 7705–7713.CrossRefPubMed Zhang, J., Su, X., Xu, W., Yu, Q., Dai, W., Wang, Y., Zhuang, X., Li, Q., Wang, X. S., & Shi, Q. (2022). Identifying patients who suffered from post-discharge cough after lung cancer surgery. Supportive Care in Cancer, 30(9), 7705–7713.CrossRefPubMed
8.
go back to reference Wang, K. Y., Chang, N. W., Wu, T. H., Hsu, C. C., Lee, Y. H., & Lee, S. C. (2010). Post-discharge health care needs of patients after lung cancer resection. Journal of Clinical Nursing, 19(17–18), 2471–2480.CrossRefPubMed Wang, K. Y., Chang, N. W., Wu, T. H., Hsu, C. C., Lee, Y. H., & Lee, S. C. (2010). Post-discharge health care needs of patients after lung cancer resection. Journal of Clinical Nursing, 19(17–18), 2471–2480.CrossRefPubMed
9.
go back to reference Lowery, A. E., Krebs, P., Coups, E. J., Feinstein, M. B., Burkhalter, J. E., Park, B. J., & Ostroff, J. S. (2014). Impact of symptom burden in post-surgical non-small cell lung cancer survivors. Supportive Care in Cancer, 22(1), 173–180.CrossRefPubMed Lowery, A. E., Krebs, P., Coups, E. J., Feinstein, M. B., Burkhalter, J. E., Park, B. J., & Ostroff, J. S. (2014). Impact of symptom burden in post-surgical non-small cell lung cancer survivors. Supportive Care in Cancer, 22(1), 173–180.CrossRefPubMed
10.
go back to reference Dai, W., Feng, W., Zhang, Y., Wang, X. S., Liu, Y., Pompili, C., Xu, W., Xie, S., Wang, Y., Liao, J., Wei, X., Xiang, R., Hu, B., Tian, B., Yang, X., Wang, X., Xiao, P., Lai, Q., Wang, X., … Shi, Q. (2022). Patient-reported outcome-based symptom management versus usual care after lung cancer surgery: A multicenter randomized controlled trial. Journal of Clinical Oncology, 40(9), 988–996.CrossRefPubMedPubMedCentral Dai, W., Feng, W., Zhang, Y., Wang, X. S., Liu, Y., Pompili, C., Xu, W., Xie, S., Wang, Y., Liao, J., Wei, X., Xiang, R., Hu, B., Tian, B., Yang, X., Wang, X., Xiao, P., Lai, Q., Wang, X., … Shi, Q. (2022). Patient-reported outcome-based symptom management versus usual care after lung cancer surgery: A multicenter randomized controlled trial. Journal of Clinical Oncology, 40(9), 988–996.CrossRefPubMedPubMedCentral
11.
go back to reference Guidance for industry: patient-reported outcome measures: Use in medical product development to support labeling claims: draft guidance. (2006). Health and Quality of Life Outcomes, 4, 79. Guidance for industry: patient-reported outcome measures: Use in medical product development to support labeling claims: draft guidance. (2006). Health and Quality of Life Outcomes, 4, 79.
12.
go back to reference de Bono, J., Mateo, J., Fizazi, K., Saad, F., Shore, N., Sandhu, S., Chi, K. N., Sartor, O., Agarwal, N., Olmos, D., Thiery-Vuillemin, A., Twardowski, P., Mehra, N., Goessl, C., Kang, J., Burgents, J., Wu, W., Kohlmann, A., Adelman, C. A., & Hussain, M. (2020). Olaparib for metastatic castration-resistant prostate cancer. New England Journal of Medicine, 382(22), 2091–2102.CrossRefPubMed de Bono, J., Mateo, J., Fizazi, K., Saad, F., Shore, N., Sandhu, S., Chi, K. N., Sartor, O., Agarwal, N., Olmos, D., Thiery-Vuillemin, A., Twardowski, P., Mehra, N., Goessl, C., Kang, J., Burgents, J., Wu, W., Kohlmann, A., Adelman, C. A., & Hussain, M. (2020). Olaparib for metastatic castration-resistant prostate cancer. New England Journal of Medicine, 382(22), 2091–2102.CrossRefPubMed
13.
go back to reference Kallen, M. A., Yang, D., & Haas, N. (2012). A technical solution to improving palliative and hospice care. Supportive Care in Cancer, 20(1), 167–174.CrossRefPubMed Kallen, M. A., Yang, D., & Haas, N. (2012). A technical solution to improving palliative and hospice care. Supportive Care in Cancer, 20(1), 167–174.CrossRefPubMed
14.
go back to reference Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. European Journal of Cancer, 30(5), 635–642.CrossRef Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. European Journal of Cancer, 30(5), 635–642.CrossRef
15.
go back to reference Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E., & Bonomi, P. (1995). Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer, 12(3), 199–220.CrossRefPubMed Cella, D. F., Bonomi, A. E., Lloyd, S. R., Tulsky, D. S., Kaplan, E., & Bonomi, P. (1995). Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer, 12(3), 199–220.CrossRefPubMed
16.
go back to reference Mendoza, T. R., Wang, X. S., Lu, C., Palos, G. R., Liao, Z., Mobley, G. M., Kapoor, S., & Cleeland, C. S. (2011). Measuring the symptom burden of lung cancer: The validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. The Oncologist, 16(2), 217–227.CrossRefPubMedPubMedCentral Mendoza, T. R., Wang, X. S., Lu, C., Palos, G. R., Liao, Z., Mobley, G. M., Kapoor, S., & Cleeland, C. S. (2011). Measuring the symptom burden of lung cancer: The validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. The Oncologist, 16(2), 217–227.CrossRefPubMedPubMedCentral
17.
go back to reference Hollen, P. J., Gralla, R. J., Kris, M. G., & Potanovich, L. M. (1993). Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS). European Journal of Cancer, 29A(Suppl 1), S51-58.CrossRef Hollen, P. J., Gralla, R. J., Kris, M. G., & Potanovich, L. M. (1993). Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS). European Journal of Cancer, 29A(Suppl 1), S51-58.CrossRef
18.
go back to reference Dalziel, K., Li, J., Scott, A., & Clarke, P. (2018). Accuracy of patient recall for self-reported doctor visits: Is shorter recall better? Health Economics, 27(11), 1684–1698.CrossRefPubMed Dalziel, K., Li, J., Scott, A., & Clarke, P. (2018). Accuracy of patient recall for self-reported doctor visits: Is shorter recall better? Health Economics, 27(11), 1684–1698.CrossRefPubMed
19.
go back to reference Guidance for industry: Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation.[8]Food and Drug Administration.pdf. (2020). Guidance for industry: Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation.[8]Food and Drug Administration.pdf. (2020).
20.
go back to reference Rolstad, S., Adler, J., & Rydén, A. (2011). Response burden and questionnaire length: Is shorter better? A review and meta-analysis. Value Health, 14(8), 1101–1108.CrossRefPubMed Rolstad, S., Adler, J., & Rydén, A. (2011). Response burden and questionnaire length: Is shorter better? A review and meta-analysis. Value Health, 14(8), 1101–1108.CrossRefPubMed
21.
go back to reference Gabrilove, J. L., Perez, E. A., Tomita, D. K., Rossi, G., & Cleeland, C. S. (2007). Assessing symptom burden using the M.D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks. Cancer, 110(7), 1629–1640.CrossRefPubMed Gabrilove, J. L., Perez, E. A., Tomita, D. K., Rossi, G., & Cleeland, C. S. (2007). Assessing symptom burden using the M.D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks. Cancer, 110(7), 1629–1640.CrossRefPubMed
22.
go back to reference Northouse, L. L., Mood, D. W., Schafenacker, A., Montie, J. E., Sandler, H. M., Forman, J. D., Hussain, M., Pienta, K. J., Smith, D. C., & Kershaw, T. (2007). Randomized clinical trial of a family intervention for prostate cancer patients and their spouses. Cancer, 110(12), 2809–2818.CrossRefPubMed Northouse, L. L., Mood, D. W., Schafenacker, A., Montie, J. E., Sandler, H. M., Forman, J. D., Hussain, M., Pienta, K. J., Smith, D. C., & Kershaw, T. (2007). Randomized clinical trial of a family intervention for prostate cancer patients and their spouses. Cancer, 110(12), 2809–2818.CrossRefPubMed
23.
go back to reference Bennett, A. V., Patrick, D. L., Bushnell, D. M., Chiou, C. F., & Diehr, P. (2011). Comparison of 7-day and repeated 24-h recall of type 2 diabetes. Quality of Life Research, 20(5), 769–777.CrossRefPubMed Bennett, A. V., Patrick, D. L., Bushnell, D. M., Chiou, C. F., & Diehr, P. (2011). Comparison of 7-day and repeated 24-h recall of type 2 diabetes. Quality of Life Research, 20(5), 769–777.CrossRefPubMed
24.
go back to reference Schaffer, E. M., Basch, E. M., Schwab, G. M., & Bennett, A. V. (2021). Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer. Clinical Trials, 18(4), 408–416.CrossRefPubMed Schaffer, E. M., Basch, E. M., Schwab, G. M., & Bennett, A. V. (2021). Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer. Clinical Trials, 18(4), 408–416.CrossRefPubMed
25.
go back to reference Shi, Q., Trask, P. C., Wang, X. S., Mendoza, T. R., Apraku, W. A., Malekifar, M., & Cleeland, C. S. (2010). Does recall period have an effect on cancer patients’ ratings of the severity of multiple symptoms? Journal of Pain and Symptom Management, 40(2), 191–199.CrossRefPubMedPubMedCentral Shi, Q., Trask, P. C., Wang, X. S., Mendoza, T. R., Apraku, W. A., Malekifar, M., & Cleeland, C. S. (2010). Does recall period have an effect on cancer patients’ ratings of the severity of multiple symptoms? Journal of Pain and Symptom Management, 40(2), 191–199.CrossRefPubMedPubMedCentral
26.
go back to reference 28th Annual Conference of the International Society for Quality of Life Research. (2021). Quality of Life Research, 30(Suppl 1), 1–177. 28th Annual Conference of the International Society for Quality of Life Research. (2021). Quality of Life Research, 30(Suppl 1), 1–177.
27.
go back to reference El Miedany, Y., El Gaafary, M., Youssef, S., Ahmed, I., & Palmer, D. (2014). The arthritic patients’ perspective of measuring treatment efficacy: Patient Reported Experience Measures (PREMs) as a quality tool. Clinical and Experimental Rheumatology, 32(4), 547–552.PubMed El Miedany, Y., El Gaafary, M., Youssef, S., Ahmed, I., & Palmer, D. (2014). The arthritic patients’ perspective of measuring treatment efficacy: Patient Reported Experience Measures (PREMs) as a quality tool. Clinical and Experimental Rheumatology, 32(4), 547–552.PubMed
28.
go back to reference Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., de Haes, J. C., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.CrossRefPubMed Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., de Haes, J. C., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.CrossRefPubMed
29.
go back to reference Kaasa, S., Bjordal, K., Aaronson, N., Moum, T., Wist, E., Hagen, S., & Kvikstad, A. (1995). The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. European Journal of Cancer, 31(13–14), 2260–2263.CrossRef Kaasa, S., Bjordal, K., Aaronson, N., Moum, T., Wist, E., Hagen, S., & Kvikstad, A. (1995). The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. European Journal of Cancer, 31(13–14), 2260–2263.CrossRef
31.
go back to reference Bartko, J. J. (1966). The intraclass correlation coefficient as a measure of reliability. Psychological Reports, 19(1), 3–11.CrossRefPubMed Bartko, J. J. (1966). The intraclass correlation coefficient as a measure of reliability. Psychological Reports, 19(1), 3–11.CrossRefPubMed
32.
go back to reference Fayers, P. M., & Machin, D. (2000). Quality of life: Assessment, analysis and interpretation. Sons Ltd.CrossRef Fayers, P. M., & Machin, D. (2000). Quality of life: Assessment, analysis and interpretation. Sons Ltd.CrossRef
33.
go back to reference Juniper, E. F., Guyatt, G. H., & Jaeschke, R. (1996). How to develop and validate a new health-related quality of life instrument. In B. Spilker (Ed.), Quality of Life and Pharmacoeconomics in Clinical Trials. Lippincott-Raven. Juniper, E. F., Guyatt, G. H., & Jaeschke, R. (1996). How to develop and validate a new health-related quality of life instrument. In B. Spilker (Ed.), Quality of Life and Pharmacoeconomics in Clinical Trials. Lippincott-Raven.
34.
go back to reference Selby, D., Cascella, A., Gardiner, K., Do, R., Moravan, V., Myers, J., & Chow, E. (2010). A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. Journal of Pain and Symptom Management, 39(2), 241–249.CrossRefPubMed Selby, D., Cascella, A., Gardiner, K., Do, R., Moravan, V., Myers, J., & Chow, E. (2010). A single set of numerical cutpoints to define moderate and severe symptoms for the Edmonton Symptom Assessment System. Journal of Pain and Symptom Management, 39(2), 241–249.CrossRefPubMed
35.
go back to reference Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174.CrossRefPubMed Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174.CrossRefPubMed
36.
go back to reference Xu, W., Dai, W., Gao, Z., Wang, X. S., Tang, L., Pu, Y., Yu, Q., Yu, H., Nie, Y., Zhuang, W., Qiao, G., Cleeland, C. S., & Shi, Q. (2022). Establishment of minimal clinically important improvement for patient-reported symptoms to define recovery after video-assisted thoracoscopic surgery. Annals of Surgical Oncology, 29(9), 5593–5604.CrossRefPubMed Xu, W., Dai, W., Gao, Z., Wang, X. S., Tang, L., Pu, Y., Yu, Q., Yu, H., Nie, Y., Zhuang, W., Qiao, G., Cleeland, C. S., & Shi, Q. (2022). Establishment of minimal clinically important improvement for patient-reported symptoms to define recovery after video-assisted thoracoscopic surgery. Annals of Surgical Oncology, 29(9), 5593–5604.CrossRefPubMed
37.
go back to reference Minton, P. D., & Cohen, J. (1971). Statistical power analysis for the behavioral sciences. Journal of the American Statistical Association, 66, 334.CrossRef Minton, P. D., & Cohen, J. (1971). Statistical power analysis for the behavioral sciences. Journal of the American Statistical Association, 66, 334.CrossRef
38.
go back to reference Boesen, V. B., Feldt-Rasmussen, U., Bjorner, J. B., Cramon, P. K., Grøenvold, M., Rasmussen, Å. K., & Watt, T. (2020). Shorter recall period for the thyroid-related patient-reported outcome measure ThyPRO did not change the accuracy as evaluated by repeated momentary measurements. Thyroid, 30(2), 185–191.CrossRefPubMed Boesen, V. B., Feldt-Rasmussen, U., Bjorner, J. B., Cramon, P. K., Grøenvold, M., Rasmussen, Å. K., & Watt, T. (2020). Shorter recall period for the thyroid-related patient-reported outcome measure ThyPRO did not change the accuracy as evaluated by repeated momentary measurements. Thyroid, 30(2), 185–191.CrossRefPubMed
39.
go back to reference Qin, S., Nelson, L., McLeod, L., Eremenco, S., & Coons, S. J. (2019). Assessing test-retest reliability of patient-reported outcome measures using intraclass correlation coefficients: Recommendations for selecting and documenting the analytical formula. Quality of Life Research, 28(4), 1029–1033.CrossRefPubMed Qin, S., Nelson, L., McLeod, L., Eremenco, S., & Coons, S. J. (2019). Assessing test-retest reliability of patient-reported outcome measures using intraclass correlation coefficients: Recommendations for selecting and documenting the analytical formula. Quality of Life Research, 28(4), 1029–1033.CrossRefPubMed
40.
go back to reference Yu, H., Yu, Q., Nie, Y., Xu, W., Pu, Y., Dai, W., Wei, X., & Shi, Q. (2021). Data quality of longitudinally collected patient-reported outcomes after thoracic surgery: Comparison of paper- and web-based assessments. Journal of Medical Internet Research, 23(11), e28915.CrossRefPubMedPubMedCentral Yu, H., Yu, Q., Nie, Y., Xu, W., Pu, Y., Dai, W., Wei, X., & Shi, Q. (2021). Data quality of longitudinally collected patient-reported outcomes after thoracic surgery: Comparison of paper- and web-based assessments. Journal of Medical Internet Research, 23(11), e28915.CrossRefPubMedPubMedCentral
Metagegevens
Titel
Undergoing Lung Surgery (PSA-Lung) was appropriate for symptom assessment after discharge
Auteurs
Xueyao Su
Yanyan Huang
Ruoyan Gong
Wei Xu
Wei Dai
Yang Pu
Jingwen Yu
Qingsong Yu
Lijun Zhang
Jiayuan Zhang
Qiuling Shi
Publicatiedatum
12-05-2024
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 7/2024
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-024-03636-w

Andere artikelen Uitgave 7/2024

Quality of Life Research 7/2024 Naar de uitgave